Filed: Oct. 28, 2010
Latest Update: Feb. 21, 2020
Summary: NOT PRECEDENTIAL UNITED STATES COURT OF APPEALS FOR THE THIRD CIRCUIT _ No. 10-2930 _ UNITED STATES OF AMERICA v. DAANIYAL MUHAMMAD, a/ka/ Kalil, a/k/a Officer Lil, Appellant _ On Appeal from the United States District Court for the District of Eastern Pennsylvania (D.C. No. 2-07-cr-00737-004) District Judge: Honorable Eduardo C. Robreno _ Argued October 13, 2010 Before: FUENTES, JORDAN and ALDISERT, Circuit Judges. (Filed: October 28, 2010) Peter A. Levin, Esq. (ARGUED) 1927 Hamilton Street Phi
Summary: NOT PRECEDENTIAL UNITED STATES COURT OF APPEALS FOR THE THIRD CIRCUIT _ No. 10-2930 _ UNITED STATES OF AMERICA v. DAANIYAL MUHAMMAD, a/ka/ Kalil, a/k/a Officer Lil, Appellant _ On Appeal from the United States District Court for the District of Eastern Pennsylvania (D.C. No. 2-07-cr-00737-004) District Judge: Honorable Eduardo C. Robreno _ Argued October 13, 2010 Before: FUENTES, JORDAN and ALDISERT, Circuit Judges. (Filed: October 28, 2010) Peter A. Levin, Esq. (ARGUED) 1927 Hamilton Street Phil..
More
NOT PRECEDENTIAL
UNITED STATES COURT OF APPEALS
FOR THE THIRD CIRCUIT
__________
No. 10-2930
__________
UNITED STATES OF AMERICA
v.
DAANIYAL MUHAMMAD,
a/ka/ Kalil, a/k/a Officer Lil,
Appellant
__________
On Appeal from the United States District Court
for the District of Eastern Pennsylvania
(D.C. No. 2-07-cr-00737-004)
District Judge: Honorable Eduardo C. Robreno
__________
Argued October 13, 2010
Before: FUENTES, JORDAN and ALDISERT, Circuit Judges.
(Filed: October 28, 2010)
Peter A. Levin, Esq. (ARGUED)
1927 Hamilton Street
Philadelphia, PA 19130
Counsel for Appellant
Salvatore L. Astolfi, Esq. (ARGUED)
Kathy A. Stark, Esq.
1
Office of the United States Attorney
615 Chestnut Street
Suite 1250
Philadelphia, PA 19106
Counsel for Appellee
__________
OPINION OF THE COURT
__________
ALDISERT, Circuit Judge.
Daaniyal Muhammad appeals from the District Court for the Eastern District of
Pennsylvania, which ordered that he be made fit for trial by medicating him against his
will. In limited circumstances, Sell v. United States,
539 U.S. 166 (2003), authorizes such
orders if the Court makes four predicate findings. Before a court reaches Sell’s four-part
inquiry, however, the government ordinarily must show why medication cannot be
administered pursuant to other procedures, such as those described in Washington v.
Harper,
494 U.S. 210 (1990), or 28 C.F.R. § 549.43. United States v. Grape,
549 F.3d
591, 599 (3d Cir. 2008) (“We do not reach consideration of the four-factor Sell test
unless an inmate does not qualify for forcible medication under Harper”). This case is
unusual in that Muhammad expressly waived any claim or right he may have had under
Harper or § 549.43. As a result, the sole question we must answer is whether the District
Court properly applied Sell. We hold that it did, and will affirm.1
I.
1
The District Court had jurisdiction under 18 U.S.C. § 3231 because Muhammad was
charged with violating the laws of the United States. We have jurisdiction under the
collateral order exception to 28 U.S.C. § 1291.
Grape, 549 F.3d at 597.
2
We write for the parties in this case only, and we state the facts and the District
Court procedures only as necessary to explain our reasoning.
Muhammad, who was indicted for conspiring to distribute crack cocaine, suffers
from schizophrenia and other mental disorders. Although profoundly disabled by these
diseases, Muhammad refuses antipsychotic medication, and declines to participate in
psychotherapy or any other form of mental health treatment. In his un-medicated state, he
is unable to appreciate the charges against him or to assist in his defense, and as a result
he is unfit to stand trial. To restore Muhammad’s competency, the government moved for
the District Court to order him medicated pursuant to Sell. The District Court granted the
government’s motion after applying Sell’s four-part balancing test, and Muhammad
appealed.
Before oral argument, we requested additional briefing on whether Muhammad’s
condition poses a danger to himself or others, thus triggering the due process procedures
mandated by § 549.43 and
Harper, 494 U.S. at 210. The government contended that
Harper and § 549.43 were not relevant and Muhammad agreed, stating that they were
“not appropriate in this case as there was no evidence that Appellant posed a danger to
others.” Because neither party disputed Muhammad’s rights or remedies under Harper
and § 549.43, we do not reach those issues. See United States v. Hernandez-Vasquez,
513
F.3d 908, 915 (9th Cir. 2008) (holding that a district court did not err in “honoring the
parties’ agreement to proceed directly to the Sell inquiry.”).
II.
We begin with the law of pre-conviction involuntary medication. If, as in this case,
3
a district court finds a criminal defendant is incompetent to stand trial, the court must
commit the defendant to the custody of the Attorney General. 18 U.S.C. § 4241. The
Attorney General must hospitalize and treat the defendant until competency returns,
unless medical professionals determine that to do so would require an unreasonable
amount of time.
Id. § 4241(d).
While in the Attorney General’s custody, inmates maintain substantial liberty
interests, including the interest in avoiding unwanted medication.
Harper, 494 U.S. at 229
(“The forcible injection of medication into a nonconsenting person’s body represents a
substantial interference with that person’s liberty.”). “In the case of antipsychotic drugs,”
like the ones Muhammad may be given, “that interference is particularly severe: [t]he
purpose of the drugs is to alter the chemical balance in a patient’s brain, leading to
changes, intended to be beneficial, in his or her cognitive processes. While the
therapeutic benefits of antipsychotic drugs are well documented, it is also true that the
drugs can have serious, even fatal, side effects.” Riggins v. Nevada,
504 U.S. 127, 134
(1992) (citations omitted).
Nonetheless, upon “a finding of overriding justification and a determination of
medical appropriateness,” a defendant’s liberty interest may yield to the legitimate needs
of government.
Id. at 135. The Sell Court recognized that Riggins “will permit
involuntary administration of drugs solely for trial competence purposes in certain
instances,” adding, “[b]ut those instances may be
rare.” 539 U.S. at 180; cf. United States
v. McCray,
474 F. Supp. 2d 671, 678 (D.N.J. 2007); United States v. Dumeny, 295 F.
Supp. 2d 131, 132-133 (D. Me. 2004). Sell authorizes such orders only in the limited
4
circumstances where (1) important governmental interests are at stake, (2) involuntary
medication will significantly further those concomitant state interests, (3) involuntary
medication is necessary to further those interests, and (4) involuntary medication is
medically appropriate, i.e., in the patient’s best medical interest in light of his medical
condition. 539 U.S. at 180-181; see also United States v. Gomes,
387 F.3d 157, 160 (2d
Cir. 2004).
III.
We will affirm the District Court’s order. The absence of dispute regarding Harper
and § 549.43 limits us to the narrow question of whether the Court properly applied the
four Sell factors. We have reviewed the record and we are satisfied that the Court’s
opinion responded to the contentions Muhammad has made before us. We will affirm its
judgment without further discussion.
5